NCT03901313 - Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

May 8, 2019

Study Completion Date

May 22, 2019

Conditions

Healthy Volunteers

Interventions

DRUG

Treatment A - 400 mg Fasting

Single oral 400 mg (2 × 200 mg capsules) dose of pexidartinib in the morning under fasting conditions

DRUG

Treatment B - 400 mg Fed

Single oral 400 mg (2 × 200 mg capsules) dose of pexidartinib in the morning within 30 minutes (min) after a low-fat standard breakfast meal

DRUG

Treatment C - 200 mg Fed

Single oral 200 mg (1 × 200 mg capsule) dose of pexidartinib in the morning within 30 min after a low-fat standard breakfast meal

Trial Locations (1)

Worldwide Clinical Trials, San Antonio